AC Immune (ACIU) Operating Leases (2017 - 2025)
Historic Operating Leases for AC Immune (ACIU) over the last 10 years, with Q3 2025 value amounting to $4.5 million.
- AC Immune's Operating Leases rose 6393.22% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 6393.22%. This contributed to the annual value of $5.0 million for FY2024, which is 9984.23% down from last year.
- Latest data reveals that AC Immune reported Operating Leases of $4.5 million as of Q3 2025, which was up 6393.22% from $4.7 million recorded in Q2 2025.
- In the past 5 years, AC Immune's Operating Leases registered a high of $3.2 billion during Q4 2023, and its lowest value of $2.0 million during Q3 2022.
- Over the past 5 years, AC Immune's median Operating Leases value was $3.0 million (recorded in 2024), while the average stood at $639.6 million.
- Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 14013259.43% in 2021, then tumbled by 9990.92% in 2022.
- Over the past 5 years, AC Immune's Operating Leases (Quarter) stood at $2.5 billion in 2021, then crashed by 99.91% to $2.3 million in 2022, then skyrocketed by 136079.37% to $3.2 billion in 2023, then tumbled by 99.84% to $5.0 million in 2024, then fell by 10.02% to $4.5 million in 2025.
- Its Operating Leases stands at $4.5 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.6 million for Q1 2025.